Literature DB >> 1976190

Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis.

M Fusconi, M Lenzi, G Ballardini, R Miniero, F Cassani, D Zauli, F B Bianchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976190     DOI: 10.1016/0140-6736(90)93297-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

Authors:  M P Manns; K J Griffin; K F Sullivan; E F Johnson
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Authors:  L Muratori; M Lenzi; Y Ma; M Cataleta; G Mieli-Vergani; D Vergani; F B Bianchi
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?

Authors:  B P Rowan; A Smith; D Gleeson; L P Hunt; T W Warnes
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

4.  Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.

Authors:  R Seelig; M Renz; G Bünger; H Schröter; H P Seelig
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

Review 5.  Hepatitis C virus. A review.

Authors:  E Tang
Journal:  West J Med       Date:  1991-08

6.  Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.

Authors:  M Lenzi; P Manotti; L Muratori; M Cataleta; G Ballardini; F Cassani; F B Bianchi
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.